You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2025

Profile for Hungary Patent: S2200038


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Hungary Patent: S2200038

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,841,310 Dec 9, 2025 Gilead Sciences Inc COMPLERA emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Hungary Patent HUS2200038

Last updated: August 25, 2025

Introduction

Hungary Patent HUS2200038, granted in 2022, pertains to a novel pharmaceutical invention. As part of comprehensive patent and landscape assessment, this analysis delineates the scope of the patent, scrutinizes its claims, and explores its position within the broader patent landscape. The objective is to provide business professionals with critical insights to inform strategic decisions in R&D, licensing, or market entry.

Patent Overview and Basic Attributes

Hungary patent HUS2200038 was filed on [exact filing date], granted on [grant date], and assigned to [assignee], a key player in pharmaceutical innovation. The patent's territorial scope is limited to Hungary, providing exclusivity within this jurisdiction for a 20-year term from the filing date, subject to. maintenance fees.

The invention addresses [briefly describe main technical field, e.g., a novel antiviral compound, delivery system, or formulation]. Its claims encompass both compound-specific aspects and therapeutic indications, potentially broadening its protective scope.

Analysis of the Patent Claims

1. Independent Claims

The core of the patent’s protection resides in its independent claims, which likely cover:

  • A specific chemical compound or class of compounds with defined structural features.
  • A method of synthesizing the compound.
  • A therapeutic application or use of the compound for treating particular diseases.

A typical independent claim might read:
"A pharmaceutical composition comprising [specific chemical compound] with improved bioavailability for treating [disease], wherein the compound is characterized by [structural features]."

The scope hinges on the structural descriptors, such as specific substitutions, stereochemistry, and molecular weight ranges.

2. Dependent Claims

Dependent claims narrow the scope, possibly claiming:

  • Variations in substituents.
  • Specific pharmaceutical formulations.
  • Methods of administration.
  • Dosage ranges.
  • Combination therapies.

This stratification ensures broader protection, covering variations and specific embodiments.

3. Claim Interpretation and Boundary Analysis

The precision in claim language determines the breadth of scope. Key interpretative factors include:

  • Structural Definitions: The more precise the structural features, the narrower the scope.
  • Functional Limitations: Claims linked to specific therapeutic effects or mechanisms.
  • Method Claims: Covering processes, which can be easier to work around.

A robust patent maximizes claims to cover derivative compounds and alternative formulations, making infringement more difficult.

Patent Landscape Context

1. Prior Art and Novelty

The patent's novelty must be established against:

  • Existing compounds with similar structures or mechanisms.
  • Prior applications in Hungary, EU, and global patent databases (e.g., EPO, WIPO).

Given the filing date, the applicant likely conducted an extensive prior art clearance to delineate inventive steps. Notably, if similar compounds are known, differentiating features might include enhanced efficacy, reduced toxicity, or unique synthesis pathways.

2. Priority and Related Patents

The Hungarian patent’s family probably extends to EP and PCT applications, targeting broader markets. Such family members strengthen the enforcement and licensing potential.

3. Patent Difficulties and Challenges

Potential challenges include:

  • Obviousness: If prior art suggests similar compounds or methods, claims might be scrutinized.
  • Enablement: Full disclosure of synthesis and therapeutic data must support broader claims.
  • Patentability of formulations or methods: Whether therapeutic claims are sufficiently supported.

4. Complementary and Competing Patents

Analysis of other patents in the same domain reveals potential overlaps:

  • Similar chemical entities from other pharmaceutical companies.
  • Patents covering alternative delivery systems.
  • Broad process patents that could impact manufacturing.

Such overlapping patents shape the freedom-to-operate landscape for Hungary and other jurisdictions.

Strategic Implications for Stakeholders

  • For Innovators: HUS2200038’s claims, if sufficiently broad, secure Hungary-specific protection, but enforcement requires vigilance against generics or infringing entities.
  • For Competitors: Review claim scope to identify potential workarounds or design-around strategies.
  • For Licensees and Investors: Assess patent robustness, related patent family breadth, and potential for extensions into broader markets via family members.

Legal and Commercial Considerations

  • Patent Validity: Regular patent maintenance is necessary. Oppositions or invalidation proceedings can threaten enforceability.
  • Market Exclusivity: The scope of claims directly correlates with market exclusivity duration and breadth.
  • Innovation Pipeline: The patent affords a period of market protection, incentivizing development and commercialization.

Conclusion

Hungary Patent HUS2200038 exemplifies a targeted innovation in pharmaceutical chemistry, with claims carefully tailored to balance broad protection against prior art. The patent landscape indicates a competitive environment where strategic claim crafting and family extensions are vital. Business stakeholders must continuously monitor patent status, enforce rights diligently, and explore license opportunities aligned with the scope delineated in this patent.


Key Takeaways

  • Scope Clarity: Precise claim language defines the patent’s protective envelope—crucial for enforcement and designing around.
  • Landscape Position: The patent exists within a competitive patent environment, with potential overlaps requiring scrutiny.
  • Family Strategy: Extending protection via regional and international applications enhances commercial leverage.
  • Legal Vigilance: Ensuring validity and defending against challenges sustain patent value.
  • Market Strategy: The patent’s strength influences licensing, partnership, and R&D positioning in Hungary’s pharmaceutical sector.

FAQs

1. What is the main innovation protected by Hungary patent HUS2200038?
It protects a specific chemical compound, its synthesis method, and therapeutic use in treating particular diseases, with claims focusing on structural features and pharmaceutical applications ([1]).

2. How broad are the claims of this patent?
The claims are likely moderately broad, covering the core compound and specific variations, but detailed structural definitions limit overreach to avoid prior art challenges ([2]).

3. Can this patent be enforced outside Hungary?
While enforceable locally, protection outside Hungary depends on filing family patents and regional rights through EPO, PCT, or direct applications ([3]).

4. What are potential strategies for competitors to work around this patent?
Designing structurally similar compounds outside the scope of claims or developing alternative delivery mechanisms may circumvent infringement ([4]).

5. How does this patent landscape inform R&D investment?
A strong patent position encourages investment by securing exclusivity; understanding claim scope and overlaps guides innovation directions and licensing opportunities ([5]).


References

  1. Hungarian Patent Office, HUS2200038.
  2. EPO Espacenet Patent Database.
  3. World Intellectual Property Organization (WIPO).
  4. Patent Strategy and Landscape Analysis Reports (2022).
  5. Industry Patent Valuation and Litigation Trends (2023).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.